Delivery Order SPE2DB20D3103-SPE2DB22FN0M4

Award Date 3/17/22
Potential Completion Date 3/18/22
Potential Value $2.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,065.31 firm fixed-price delivery order covers the supply of Esomeprazole Magnesium Delayed Release 20 mg Capsules. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,209.84 delivery order contract is for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules in 30-count packages. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc., the parent company of Amerisourcebergen Drug Corp. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,753.65 firm fixed-price delivery order covers the supply of 4,565,078,957 units of Esomeprazole Magnesium delayed-release 40 mg capsules. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $3,488.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Esomeprazole Magnesium Delayed Release 40 mg capsules, a cardiovascular medication. The award is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,288.94, is for the delivery of Esomeprazole Magnesium Delayed-Release Capsules, 20 mg, in 90-count bottles. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The...
This federal contract award, valued at $1,304.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of esomeprazole magnesium delayed-release 20 mg capsules in quantities of 1,000. The contract has a completion date of May 10, 2024 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Esomeprazole Magnesium Delayed-Release capsules. The $1,506.76 firm fixed-price delivery order was placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award, valued at $6,459.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of esomeprazole magnesium delayed-release capsules, a medication used to treat conditions like gastroesophageal reflux disease. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 11, 2023. The contract is not designated with a set-aside requirement,...
This federal contract award, valued at $4,204.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,748,995 units of the medication Esomeprazole Magnesium Delayed Release 20 mg Capsules in 90-count bottles. The contract has an ultimate completion date of November 8, 2023 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,916.03 firm fixed-price delivery order is for the supply of esomeprazole magnesium delayed-release capsules, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FN0M4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,949.96 firm fixed-price delivery order is for the supply of Esomeprazole Magnesium Delayed-Release (DR) 20 mg capsules in quantities of 90s. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. The contract supports the medical needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 12:40 PM